Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Clinical trial NCT01147809 · COMPLETED
Trial details
- NCT number
- NCT01147809
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2015-01-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.